SCHEMBL4769586

SCHEMBL4769586

CCCCn1c(/C=C/c2cnn(-c3ccccc3)c2)c([N+](=O)[O-])c(=O)n(CC(C)C)c1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCOA1 Q15788 1/20 0.39
NCOA3 Q9Y6Q9 1/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 3/20 0.37
ADORA2A P29274 3/20 0.36
ADORA2B P29275 3/20 0.36
ADORA1 P30542 3/20 0.36
MAPT P10636 5/20 0.36
POLB P06746 1/20 0.36
MITF O75030 1/20 0.35
HSP90AA1 P07900 1/20 0.34
ALDH1A1 P00352 3/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
MAPK1 P28482 1/20 0.33
LMNA P02545 2/20 0.33
ADORA3 P0DMS8 2/20 0.33
KDM4E B2RXH2 1/20 0.33
CACNA1B Q00975 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4769599 1.00 NCOA1 (0.39) NCOA1NCOA3NPC1RAB9ASMN1; SMN2
SCHEMBL4767911 0.94 NCOA1 (0.42) NCOA1NCOA3NPC1RAB9ASMN1; SMN2
SCHEMBL4767902 0.94 NCOA1 (0.42) NCOA1NCOA3NPC1RAB9ASMN1; SMN2
SCHEMBL4763574 0.92 SMN1; SMN2 (0.41) NPC1RAB9ASMN1; SMN2ADORA2AADORA2B
SCHEMBL4763559 0.92 SMN1; SMN2 (0.41) NPC1RAB9ASMN1; SMN2ADORA2AADORA2B
SCHEMBL4763475 0.88 NCOA1 (0.42) NCOA1NCOA3NPC1RAB9ASMN1; SMN2
SCHEMBL4793245 0.87 NPC1 (0.36) NPC1RAB9ASMN1; SMN2ADORA2AADORA2B
SCHEMBL4793254 0.87 NPC1 (0.36) NPC1RAB9ASMN1; SMN2ADORA2AADORA2B
SCHEMBL4763471 0.86 NCOA1 (0.42) NCOA1NCOA3NPC1RAB9ASMN1; SMN2
SCHEMBL4763478 0.86 NCOA1 (0.42) NCOA1NCOA3NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678181-B1 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS INC (US) 2008-12-31 EP disclosed